Corrigendum to "Nitazoxanide superiority to placebo to treat moderate COVID-19 - A Pilot prove of concept randomized double-blind clinical trial." [EClinicalMedicine 37 (2021) 100981]
EClinicalMedicine. 2021 Nov:41:101203.
doi: 10.1016/j.eclinm.2021.101203.
Epub 2021 Nov 14.